We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
State Street
STT
$50.2B
| $677K | 0.01% |
8,613
+4,113
| +91% | +$309K |
|
|
GAS
602
DELISTED
AGL Resources Inc
GAS
| $672K | 0.01% |
12,327
-2,200
| -15% | -$116K |
|
|
GWR
603
DELISTED
Genesee & Wyoming Inc.
GWR
| $669K | 0.01% |
7,437
-56,599
| -88% | -$5.23M |
|
604
Old Republic International
ORI
$10.6B
| $667K | 0.01% |
45,549
+4,333
| +11% | +$63.3K |
|
605
Dana Inc
DAN
$2.91B
| $666K | 0.01% |
30,596
+1,254
| +4% | +$25.3K |
|
606
Spectrum Brands
SPB
$2.04B
| $664K | 0.01% |
6,935
+560
| +9% | +$51K |
|
|
CEB
607
DELISTED
CEB Inc.
CEB
| $664K | 0.01% |
9,149
-1,272
| -12% | -$87.4K |
|
608
General Mills
GIS
$19.4B
| $663K | 0.01% |
12,424
-16,501
| -57% | -$853K |
|
|
RLD
609
DELISTED
REALD INC COM STK
RLD
| $655K | 0.01% |
55,415
-57,899
| -51% | -$654K |
|
610
Vanguard FTSE Europe ETF
VGK
$30.8B
| $654K | 0.01% |
+12,448
| New | +$667K |
|
611
United Airlines
UAL
$40.1B
| $652K | 0.01% |
+9,740
| New | +$539K |
|
612
Global Payments
GPN
$23.8B
| $651K | 0.01% |
+16,108
| New | +$645K |
|
|
CPN
613
DELISTED
Calpine Corporation
CPN
| $646K | 0.01% |
29,160
-8,003
| -22% | -$178K |
|
|
SWI
614
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $639K | 0.01% |
+12,815
| New | +$610K |
|
|
MPG
615
DELISTED
Metaldyne Performance Group Inc.
MPG
| $638K | 0.01% |
+36,728
| New | +$578K |
|
616
AGCO
AGCO
$7.76B
| $636K | 0.01% |
+14,066
| New | +$623K |
|
|
CYT
617
DELISTED
CYTEC INDS INC
CYT
| $636K | 0.01% |
+13,770
| New | +$641K |
|
618
Amgen
AMGN
$209B
| $630K | 0.01% |
3,950
-207,235
| -98% | -$32.3M |
|
619
Southwest Airlines
LUV
$22.3B
| $629K | 0.01% |
14,849
-17,929
| -55% | -$669K |
|
620
PENN Entertainment
PENN
$2.75B
| $626K | 0.01% |
45,530
-1,968
| -4% | -$25.5K |
|
|
DNB
621
DELISTED
Dun & Bradstreet
DNB
| $623K | 0.01% |
+5,150
| New | +$622K |
|
|
CVC
622
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $619K | 0.01% |
29,987
-25,354
| -46% | -$483K |
|
|
ATVI
623
DELISTED
Activision Blizzard
ATVI
| $619K | 0.01% |
30,694
-66,078
| -68% | -$1.33M |
|
624
Aecom
ACM
$9.22B
| $617K | 0.01% |
20,298
+3,073
| +18% | +$95.9K |
|
625
Southern Company
SO
$106B
| $617K | 0.01% |
12,551
+2,450
| +24% | +$116K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.